Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	496.37	108.18	18.14
Graham Fair Price	-49.49	3038.53	6015.25
PEG	1553.60	0.22	-0.01
Price/Book	6.88	0.67	0.62
Price/Cash Flow	-20.31	96.99	-121.71
Prices/Earnings	314.88	-27.76	6.69
Price/Sales	2.45	1.16	1.13
Price/FCF	-20.31	96.99	-121.71
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	9.00	0.15	0.14
Operating Margin	-70.35	-0.02	0.06
ROA	-78.18	< 0.005	0.01
ROE	0.02	< 0.005	-74.24
ROIC	0.02	< 0.005	-65.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.25	0.22	15.95
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.58	-1.31	124.03
EPS QOQ	5.01	-1.26	-74.91
FCF QOQ	-1.41	2.33	65.02
Revenue QOQ	0.06	0.04	-40.83
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	46.47	49.68	6.91
Days Sales Outstanding (DSO)	79.39	97.69	23.05
Inventory Turnover	1.94	1.81	-6.46
Debt/Capitalization	0.30	0.35	16.39
Quick Ratio	0.83	0.76	-7.86
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	8309.67	10716.97	28.97
Cash	1548.41	1134.19	-26.75
Capex	-177.22	129.34	-27.01
Free Cash Flow	-42.56	56.81	33.49
Revenue	4586.53	4762.23	3.83
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.14	1.01	-11.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.69	44.66	568.06
Naive Interpretation	Member

06 - Financial Health · Bad

Rating